[et_pb_section fb_built=”1″ admin_label=”Section” module_class=”innerBanner” _builder_version=”4.24.2″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” background_image=”https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/cell-crop-orange-scaled.jpg” background_enable_video_mp4=”off” height=”500px” custom_padding=”199px||199px||true|false” bottom_divider_height=”500px” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row custom_padding_last_edited=”on|tablet” _builder_version=”4.24.2″ _module_preset=”default” width=”100%” max_width=”100%” custom_padding=”|60px||60px|false|true” custom_padding_tablet=”0px|20px|0px|20px|false|true” custom_padding_phone=”|20px||20px|false|true” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_column type=”4_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_cta _builder_version=”4.24.2″ _module_preset=”default” header_font=”Nunito Sans|700||on|||||” header_text_color=”#FFFFFF” header_font_size=”20px” header_letter_spacing=”1px” header_line_height=”20px” body_font=”Nunito Sans|300||on|||||” body_text_color=”#FFFFFF” body_font_size=”40px” body_letter_spacing=”0.5px” body_line_height=”44px” use_background_color=”off” text_orientation=”left” max_width=”500px” custom_padding=”10px||10px|25px|true|false” body_font_size_tablet=”36px” body_font_size_phone=”30px” body_font_size_last_edited=”on|tablet” border_width_left=”6px” border_color_left=”#FFFFFF” global_colors_info=”{}”]<\/p>\n
Expanded Access
policy<\/p>\n
[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Section” module_id=”scrollToNext” _builder_version=”4.24.2″ _module_preset=”default” custom_margin=”30px||0px||false|false” custom_margin_tablet=”20px||||false|false” custom_margin_phone=”20px||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” da_popup_slug=”scrollToNext” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row custom_padding_last_edited=”on|tablet” module_class=”alignItemsCenter” _builder_version=”4.24.2″ _module_preset=”default” width_tablet=”100%” width_phone=”100%” width_last_edited=”on|tablet” custom_padding=”30px||60px||false|false” custom_padding_tablet=”|20px|50px|20px|false|false” custom_padding_phone=”|20px|||false|false” border_color_top=”#3E92AC” border_color_bottom=”#F47920″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.2″ _module_preset=”default” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_heading title=”EXPANDED ACCESS POLICY” _builder_version=”4.24.2″ _module_preset=”default” title_level=”h3″ title_font=”|800|||||||” title_text_color=”#3E92AC” title_font_size=”24px” title_line_height=”28px” custom_margin=”||10px||false|false” custom_padding=”0px|||||” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_font_size=”20px” text_line_height=”27px” width=”90%” width_tablet=”100%” width_phone=”” width_last_edited=”on|tablet” hover_enabled=”0″ global_colors_info=”{}” text_font_size_last_edited=”on|tablet” sticky_enabled=”0″ text_font_size_tablet=”18px” text_font_size_phone=”18px”]<\/p>\n
Expanded access, also known as \u201ccompassionate use,\u201d refers to the use of an investigational new drug outside of a clinical trial for patients with serious or life-threatening conditions who have exhausted their treatment options and are not eligible for, or able to participate in, a clinical trial.<\/p>\n
KSQ Therapeutics, Inc. (\u201cKSQ\u201d) is committed to studying and developing our investigational therapies as part of clinical trials designed to generate adequate safety and efficacy data to evaluate the potential benefit of the therapy versus the risk, which can then be used to support regulatory approval of the investigational therapies.<\/p>\n
Clinical trials and the subsequent regulatory approval of a new therapeutic option provides the path to long-term access to treatment. We believe that focusing on current and future clinical trial programs provides the best path to meet our goal of providing therapies to patients. As such, at this time, KSQ does not have an expanded access program (EAP) that allows patients to have access to our investigational therapies outside of enrollment in our clinical trials.<\/p>\n
Information regarding our development programs and clinical trials can be found on our website or by visiting www.clinicaltrials.gov<\/a> and searching for KSQ Therapeutics.<\/p>\n If applicable, this website will be updated with hyperlinks to the relevant expanded access information on www.clinicaltrials.gov<\/a> upon activation. As authorized by the 21st Century Cures Act, KSQ reserves the right to revise this expanded access policy at any time.<\/p>\n